Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
11.26
-0.02 (-0.18%)
At close: May 30, 2025, 4:00 PM
11.25
-0.01 (-0.10%)
After-hours: May 30, 2025, 4:21 PM EDT
Orthofix Medical Market Cap
Orthofix Medical has a market cap or net worth of $440.78 million as of May 30, 2025. Its market cap has decreased by -22.37% in one year.
Market Cap
440.78M
Enterprise Value
575.59M
1-Year Change
-22.37%
Ranking
Category
Stock Price
$11.26
Market Cap Chart
Since December 1, 1998, Orthofix Medical's market cap has increased from $145.80M to $440.78M, an increase of 202.32%. That is a compound annual growth rate of 4.26%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 30, 2025 | 440.80M | -33.93% |
Dec 31, 2024 | 667.20M | 34.65% |
Dec 29, 2023 | 495.50M | 20.62% |
Dec 30, 2022 | 410.80M | -33.08% |
Dec 31, 2021 | 613.90M | -26.13% |
Dec 31, 2020 | 831.00M | -5.57% |
Dec 31, 2019 | 880.00M | -11.40% |
Dec 31, 2018 | 993.20M | -0.41% |
Dec 29, 2017 | 997.30M | 54.64% |
Dec 30, 2016 | 644.90M | -12.93% |
Dec 31, 2015 | 740.70M | 33.65% |
Dec 31, 2014 | 554.20M | 24.85% |
Dec 31, 2013 | 443.90M | -41.58% |
Dec 31, 2012 | 759.90M | 17.16% |
Dec 30, 2011 | 648.60M | 26.16% |
Dec 31, 2010 | 514.10M | -3.00% |
Dec 31, 2009 | 530.00M | 102.14% |
Dec 31, 2008 | 262.20M | -73.29% |
Dec 31, 2007 | 981.70M | 19.78% |
Dec 29, 2006 | 819.60M | 28.36% |
Dec 30, 2005 | 638.50M | 4.30% |
Dec 31, 2004 | 612.20M | -12.12% |
Dec 31, 2003 | 696.60M | 93.34% |
Dec 31, 2002 | 360.30M | -26.47% |
Dec 31, 2001 | 490.00M | 96.63% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 662.23B |
Johnson & Johnson | 373.45B |
AbbVie | 328.75B |
Novo Nordisk | 305.07B |
UnitedHealth Group | 273.87B |
Abbott Laboratories | 232.41B |
AstraZeneca | 224.00B |
Novartis AG | 223.92B |